[Hopespringpcsg] FW: Standard therapy plus abiraterone lowers relative risk of death in men with advanced prostate cancer

Glen Tolhurst glen46nor at gmail.com
Mon Jun 5 14:08:51 EDT 2017

Previous message: [Hopespringpcsg] FW: HopeSpring Weekly Newsletter for June 5
Next message: [Hopespringpcsg] FW: ASCO: 18 Month ADT Enough in High-Risk Prostate Cancer?
Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]



Hi all:
See below for link to an interesting article.
Thx.
Glen


https://www.yahoo.com/news/m/92eeb40f-26f4-37d4-a002-7ecc273579e9/standard-t
herapy-plus.html?.tsrc=daily_mail&uh_test=2_08

Previous message: [Hopespringpcsg] FW: HopeSpring Weekly Newsletter for June 5
Next message: [Hopespringpcsg] FW: ASCO: 18 Month ADT Enough in High-Risk Prostate Cancer?
Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]

More information about the Hopespringpcsg mailing list